SENSible Question: Is Targeting Beta-Amyloid Founded on Fraud?
A supporter asks about the investigative report in Science magazine that suggests the critical study identifying beta-amyloid oligomers as the key actors in Alzheimer’s disease may have been based on fraudulent data.